Funder: Pershing Square Philanthropies
Due Dates (Anticipated): October 2027 (Letter of Intent)
Funding Amounts: $750,000 over three years ($250,000 annually, including indirect costs)
Summary: Supports early-career U.S. scientists pursuing radically innovative, high-risk cancer research with potential for transformative discoveries.
Key Information: Applicants must have two to six years of independent laboratory experience and may apply only twice.
Description
The Pershing Square Sohn Cancer Prize is awarded by the Pershing Square Sohn Cancer Research Alliance (PSSCRA) to give early-career scientists freedom to pursue bold research when traditional funding is lacking. The annual prize supports scientifically sound, high-risk, high-reward projects, including basic research and technological applications, that could advance cancer understanding, diagnosis, prevention, or treatment.
The program seeks radically novel approaches with a strong scientific rationale and potential to shift paradigms or address unmet needs. Alongside funding, PSSCRA connects investigators with academic researchers, industry mentors, and philanthropic and for-profit investors. These relationships aim to accelerate collaboration between science and business, help promising discoveries gain traction, and advance the pursuit of cancer cures.
